bpc-157 human clinical trials 2026 FDA panel votes to place popular peptide on compounding list International Clinical Trials Day 2026:

SS-31 is a cell-permeable peptide that concentrates on the inner mitochondrial membrane, where it stabilizes cardiolipin and protects the electron transport chain from oxidative damage

This binding suppresses TNF-alpha and IL-6 while modulating downstream inflammatory pathways

Sirtuins regulate gene expression, DNA repair, mitochondrial biogenesis, inflammation, and circadian rhythm but are directly dependent on adequate NAD+ availability to function

I also invite you to join me and other like-minded biohackers in The Fully Optimized Health Private Membership Group

This favors the possible controlling role of the BPC 157

What Is a B12 Injection